Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lyme Neuroborreliosis | 2 | 2018 | 51 | 1.190 |
Why?
|
| Herpes Zoster | 5 | 2019 | 264 | 1.050 |
Why?
|
| Endocrine System Diseases | 1 | 2023 | 248 | 0.770 |
Why?
|
| Hypothyroidism | 1 | 2023 | 659 | 0.630 |
Why?
|
| Paresthesia | 1 | 2018 | 162 | 0.610 |
Why?
|
| MELAS Syndrome | 1 | 2017 | 50 | 0.580 |
Why?
|
| Peripheral Nervous System Diseases | 4 | 2019 | 700 | 0.520 |
Why?
|
| Diplopia | 1 | 2016 | 199 | 0.520 |
Why?
|
| Mononeuropathies | 1 | 2012 | 16 | 0.430 |
Why?
|
| Polyradiculopathy | 1 | 2011 | 24 | 0.400 |
Why?
|
| Ataxia | 1 | 2011 | 304 | 0.340 |
Why?
|
| Headache | 1 | 2016 | 1219 | 0.330 |
Why?
|
| Rheumatic Diseases | 1 | 2014 | 590 | 0.310 |
Why?
|
| Celiac Disease | 1 | 2014 | 785 | 0.290 |
Why?
|
| Pain Measurement | 2 | 2013 | 3418 | 0.240 |
Why?
|
| Pain | 4 | 2014 | 4961 | 0.230 |
Why?
|
| Central Nervous System Diseases | 2 | 2021 | 518 | 0.220 |
Why?
|
| Peripheral Nerves | 2 | 2019 | 474 | 0.220 |
Why?
|
| Diagnosis, Differential | 5 | 2022 | 12958 | 0.210 |
Why?
|
| Sarcoidosis | 2 | 2021 | 503 | 0.200 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2022 | 265 | 0.180 |
Why?
|
| Vasculitis | 1 | 2023 | 521 | 0.170 |
Why?
|
| Abdominal Wall | 1 | 2018 | 155 | 0.150 |
Why?
|
| Genes, Mitochondrial | 1 | 2017 | 61 | 0.150 |
Why?
|
| Acidosis, Lactic | 1 | 2017 | 142 | 0.130 |
Why?
|
| Foot | 1 | 2018 | 528 | 0.130 |
Why?
|
| Back Pain | 1 | 2018 | 545 | 0.120 |
Why?
|
| Thoracic Vertebrae | 1 | 2018 | 604 | 0.120 |
Why?
|
| Autoantibodies | 1 | 2022 | 2036 | 0.110 |
Why?
|
| Paresis | 1 | 2014 | 179 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2022 | 1060 | 0.110 |
Why?
|
| Isoquinolines | 1 | 2014 | 368 | 0.100 |
Why?
|
| Fatal Outcome | 1 | 2017 | 1849 | 0.100 |
Why?
|
| Diet, Gluten-Free | 1 | 2014 | 271 | 0.100 |
Why?
|
| Prodrugs | 1 | 2014 | 268 | 0.100 |
Why?
|
| DNA, Mitochondrial | 1 | 2017 | 814 | 0.100 |
Why?
|
| Paraparesis | 1 | 2011 | 14 | 0.100 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2014 | 449 | 0.100 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2017 | 770 | 0.090 |
Why?
|
| Neural Conduction | 1 | 2012 | 468 | 0.090 |
Why?
|
| Neuralgia, Postherpetic | 1 | 2010 | 38 | 0.090 |
Why?
|
| Brain | 1 | 2017 | 26343 | 0.090 |
Why?
|
| Autoimmune Diseases | 1 | 2022 | 2130 | 0.090 |
Why?
|
| Hyperalgesia | 2 | 2011 | 502 | 0.090 |
Why?
|
| Muscle Weakness | 1 | 2012 | 414 | 0.080 |
Why?
|
| Fever | 1 | 2016 | 1612 | 0.080 |
Why?
|
| Tetrazoles | 1 | 2014 | 835 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2022 | 4414 | 0.070 |
Why?
|
| Sensation Disorders | 1 | 2007 | 156 | 0.070 |
Why?
|
| Humans | 19 | 2023 | 742088 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2018 | 35342 | 0.070 |
Why?
|
| Continuity of Patient Care | 1 | 2012 | 1048 | 0.060 |
Why?
|
| Migraine Disorders | 1 | 2017 | 1620 | 0.060 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2011 | 1123 | 0.060 |
Why?
|
| Phytotherapy | 1 | 2007 | 298 | 0.060 |
Why?
|
| Action Potentials | 1 | 2012 | 1814 | 0.060 |
Why?
|
| Seizures | 1 | 2017 | 2851 | 0.060 |
Why?
|
| Male | 13 | 2023 | 349538 | 0.060 |
Why?
|
| Neurology | 1 | 2012 | 762 | 0.060 |
Why?
|
| Disease Progression | 2 | 2011 | 13256 | 0.060 |
Why?
|
| Analgesics | 1 | 2011 | 1037 | 0.060 |
Why?
|
| Adult | 7 | 2023 | 213712 | 0.060 |
Why?
|
| Middle Aged | 9 | 2018 | 213127 | 0.050 |
Why?
|
| Aged, 80 and over | 6 | 2014 | 57683 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 4933 | 0.050 |
Why?
|
| Motor Neuron Disease | 1 | 2022 | 106 | 0.050 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2023 | 286 | 0.050 |
Why?
|
| Cannabis | 1 | 2007 | 432 | 0.050 |
Why?
|
| Peroxidase | 1 | 2023 | 610 | 0.050 |
Why?
|
| Inflammation | 1 | 2019 | 10578 | 0.040 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2022 | 230 | 0.040 |
Why?
|
| Female | 10 | 2023 | 379592 | 0.040 |
Why?
|
| Aged | 7 | 2022 | 162944 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2022 | 657 | 0.040 |
Why?
|
| Cross-Over Studies | 2 | 2014 | 2030 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 13921 | 0.040 |
Why?
|
| Skin | 1 | 2010 | 4353 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2023 | 3862 | 0.030 |
Why?
|
| Stroke | 2 | 2017 | 9963 | 0.030 |
Why?
|
| Endarterectomy, Carotid | 1 | 2000 | 546 | 0.030 |
Why?
|
| Young Adult | 3 | 2016 | 56350 | 0.030 |
Why?
|
| Lumbosacral Plexus | 1 | 2014 | 53 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2021 | 1354 | 0.030 |
Why?
|
| Electrodiagnosis | 1 | 2014 | 154 | 0.030 |
Why?
|
| Carotid Stenosis | 1 | 2000 | 854 | 0.030 |
Why?
|
| Mutation | 1 | 2017 | 29717 | 0.030 |
Why?
|
| Brachial Plexus | 1 | 2014 | 165 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2023 | 77098 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2012 | 5774 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 39004 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2019 | 878 | 0.020 |
Why?
|
| Coronary Artery Bypass | 1 | 2000 | 2281 | 0.020 |
Why?
|
| Simplexvirus | 1 | 2014 | 802 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2013 | 40450 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 4414 | 0.020 |
Why?
|
| Upper Extremity | 1 | 2014 | 648 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2014 | 12017 | 0.020 |
Why?
|
| California | 1 | 2011 | 1400 | 0.020 |
Why?
|
| Physical Stimulation | 1 | 2007 | 525 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2000 | 6078 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 3913 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2007 | 1355 | 0.010 |
Why?
|
| HIV Infections | 1 | 2007 | 16678 | 0.010 |
Why?
|
| Affect | 1 | 2007 | 1473 | 0.010 |
Why?
|
| Patient Selection | 1 | 2011 | 4214 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2014 | 62966 | 0.010 |
Why?
|
| Communication | 1 | 2012 | 3728 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 11363 | 0.010 |
Why?
|
| Physicians | 1 | 2012 | 4554 | 0.010 |
Why?
|
| Palliative Care | 1 | 2007 | 3478 | 0.010 |
Why?
|
| Smoking | 1 | 2007 | 8969 | 0.010 |
Why?
|
| Cause of Death | 1 | 2000 | 3571 | 0.010 |
Why?
|
| Survival Rate | 1 | 2000 | 12773 | 0.000 |
Why?
|
| Comorbidity | 1 | 2000 | 10372 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2000 | 15244 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2000 | 53187 | 0.000 |
Why?
|
Concepts
(116)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_